PRO-DEX INC (PDEX) Fundamental Analysis & Valuation

NASDAQ:PDEX • US74265M2052

48.46 USD
+1.64 (+3.5%)
Last: Mar 13, 2026, 08:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This PDEX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

Taking everything into account, PDEX scores 5 out of 10 in our fundamental rating. PDEX was compared to 184 industry peers in the Health Care Equipment & Supplies industry. PDEX has an average financial health and profitability rating. PDEX has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. PDEX Profitability Analysis

1.1 Basic Checks

  • PDEX had positive earnings in the past year.
  • In the past year PDEX has reported a negative cash flow from operations.
  • PDEX had positive earnings in each of the past 5 years.
  • In multiple years PDEX reported negative operating cash flow during the last 5 years.
PDEX Yearly Net Income VS EBIT VS OCF VS FCFPDEX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M -10M

1.2 Ratios

  • The Return On Assets of PDEX (17.41%) is better than 96.74% of its industry peers.
  • PDEX has a better Return On Equity (26.96%) than 96.74% of its industry peers.
  • PDEX has a Return On Invested Capital of 16.51%. This is amongst the best in the industry. PDEX outperforms 95.11% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for PDEX is above the industry average of 9.18%.
  • The 3 year average ROIC (14.16%) for PDEX is below the current ROIC(16.51%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 17.41%
ROE 26.96%
ROIC 16.51%
ROA(3y)10.79%
ROA(5y)11.4%
ROE(3y)17.93%
ROE(5y)20.5%
ROIC(3y)14.16%
ROIC(5y)12.68%
PDEX Yearly ROA, ROE, ROICPDEX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • With an excellent Profit Margin value of 15.94%, PDEX belongs to the best of the industry, outperforming 91.85% of the companies in the same industry.
  • PDEX's Profit Margin has declined in the last couple of years.
  • PDEX's Operating Margin of 15.36% is amongst the best of the industry. PDEX outperforms 82.61% of its industry peers.
  • In the last couple of years the Operating Margin of PDEX has declined.
  • PDEX's Gross Margin of 28.09% is on the low side compared to the rest of the industry. PDEX is outperformed by 76.63% of its industry peers.
  • In the last couple of years the Gross Margin of PDEX has declined.
Industry RankSector Rank
OM 15.36%
PM (TTM) 15.94%
GM 28.09%
OM growth 3Y9.36%
OM growth 5Y-4.56%
PM growth 3Y7.44%
PM growth 5Y-5.13%
GM growth 3Y-2.11%
GM growth 5Y-4.93%
PDEX Yearly Profit, Operating, Gross MarginsPDEX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. PDEX Health Analysis

2.1 Basic Checks

  • PDEX has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for PDEX has been reduced compared to 1 year ago.
  • Compared to 5 years ago, PDEX has less shares outstanding
  • The debt/assets ratio for PDEX is higher compared to a year ago.
PDEX Yearly Shares OutstandingPDEX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M 4M
PDEX Yearly Total Debt VS Total AssetsPDEX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

  • An Altman-Z score of 7.18 indicates that PDEX is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 7.18, PDEX belongs to the best of the industry, outperforming 86.41% of the companies in the same industry.
  • A Debt/Equity ratio of 0.21 indicates that PDEX is not too dependend on debt financing.
  • With a Debt to Equity ratio value of 0.21, PDEX perfoms like the industry average, outperforming 57.61% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Altman-Z 7.18
ROIC/WACC1.65
WACC10%
PDEX Yearly LT Debt VS Equity VS FCFPDEX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M 30M

2.3 Liquidity

  • A Current Ratio of 3.73 indicates that PDEX has no problem at all paying its short term obligations.
  • PDEX's Current ratio of 3.73 is fine compared to the rest of the industry. PDEX outperforms 63.59% of its industry peers.
  • PDEX has a Quick Ratio of 2.14. This indicates that PDEX is financially healthy and has no problem in meeting its short term obligations.
  • PDEX has a Quick ratio of 2.14. This is comparable to the rest of the industry: PDEX outperforms 54.89% of its industry peers.
Industry RankSector Rank
Current Ratio 3.73
Quick Ratio 2.14
PDEX Yearly Current Assets VS Current LiabilitesPDEX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. PDEX Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 61.19% over the past year.
  • PDEX shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.96% yearly.
  • Looking at the last year, PDEX shows a very strong growth in Revenue. The Revenue has grown by 23.68%.
  • The Revenue has been growing by 13.84% on average over the past years. This is quite good.
EPS 1Y (TTM)61.19%
EPS 3Y35.1%
EPS 5Y10.96%
EPS Q2Q%8.2%
Revenue 1Y (TTM)23.68%
Revenue growth 3Y16.57%
Revenue growth 5Y13.84%
Sales Q2Q%11.12%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-4.43%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.48%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PDEX Yearly Revenue VS EstimatesPDEX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
PDEX Yearly EPS VS EstimatesPDEX Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

More info and screens

Find the best growth stocksShow best growing peers

4

4. PDEX Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 14.96 indicates a correct valuation of PDEX.
  • Based on the Price/Earnings ratio, PDEX is valued cheaply inside the industry as 86.41% of the companies are valued more expensively.
  • PDEX is valuated rather cheaply when we compare the Price/Earnings ratio to 25.70, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 19.96, PDEX is valued on the expensive side.
  • 79.35% of the companies in the same industry are more expensive than PDEX, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.84, PDEX is valued at the same level.
Industry RankSector Rank
PE 14.96
Fwd PE 19.96
PDEX Price Earnings VS Forward Price EarningsPDEX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 86.96% of the companies in the same industry are more expensive than PDEX, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.88
PDEX Per share dataPDEX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • PDEX has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.36
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PDEX Dividend Analysis

5.1 Amount

  • PDEX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PDEX Fundamentals: All Metrics, Ratios and Statistics

PRO-DEX INC

NASDAQ:PDEX (3/13/2026, 8:00:00 PM)

48.46

+1.64 (+3.5%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-29
Earnings (Next)04-29
Inst Owners32.13%
Inst Owner Change-6.03%
Ins Owners36.66%
Ins Owner Change1.64%
Market Cap155.56M
Revenue(TTM)66.59M
Net Income(TTM)11.19M
Analysts82.86
Price Target57.12 (17.87%)
Short Float %11.28%
Short Ratio8.46
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)74.8%
Min EPS beat(2)-24.91%
Max EPS beat(2)174.51%
EPS beat(4)3
Avg EPS beat(4)69.51%
Min EPS beat(4)-24.91%
Max EPS beat(4)174.51%
EPS beat(8)5
Avg EPS beat(8)44.11%
EPS beat(12)7
Avg EPS beat(12)20.2%
EPS beat(16)8
Avg EPS beat(16)16.17%
Revenue beat(2)1
Avg Revenue beat(2)7.28%
Min Revenue beat(2)-4.18%
Max Revenue beat(2)18.74%
Revenue beat(4)2
Avg Revenue beat(4)7.58%
Min Revenue beat(4)-4.18%
Max Revenue beat(4)19.3%
Revenue beat(8)6
Avg Revenue beat(8)12.93%
Revenue beat(12)9
Avg Revenue beat(12)11.32%
Revenue beat(16)12
Avg Revenue beat(16)11.48%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 14.96
Fwd PE 19.96
P/S 2.21
P/FCF N/A
P/OCF N/A
P/B 3.75
P/tB 3.75
EV/EBITDA 11.88
EPS(TTM)3.24
EY6.69%
EPS(NY)2.43
Fwd EY5.01%
FCF(TTM)-0.68
FCFYN/A
OCF(TTM)-0.39
OCFYN/A
SpS21.88
BVpS12.93
TBVpS12.93
PEG (NY)N/A
PEG (5Y)1.36
Graham Number30.7
Profitability
Industry RankSector Rank
ROA 17.41%
ROE 26.96%
ROCE 21.27%
ROIC 16.51%
ROICexc 20.85%
ROICexgc 20.86%
OM 15.36%
PM (TTM) 15.94%
GM 28.09%
FCFM N/A
ROA(3y)10.79%
ROA(5y)11.4%
ROE(3y)17.93%
ROE(5y)20.5%
ROIC(3y)14.16%
ROIC(5y)12.68%
ROICexc(3y)16.6%
ROICexc(5y)14.6%
ROICexgc(3y)16.62%
ROICexgc(5y)14.63%
ROCE(3y)18.25%
ROCE(5y)16.34%
ROICexgc growth 3Y23.73%
ROICexgc growth 5Y-8.41%
ROICexc growth 3Y23.84%
ROICexc growth 5Y-8.25%
OM growth 3Y9.36%
OM growth 5Y-4.56%
PM growth 3Y7.44%
PM growth 5Y-5.13%
GM growth 3Y-2.11%
GM growth 5Y-4.93%
F-Score6
Asset Turnover1.09
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Debt/EBITDA 0.72
Cap/Depr 73.12%
Cap/Sales 1.3%
Interest Coverage 12.57
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.73
Quick Ratio 2.14
Altman-Z 7.18
F-Score6
WACC10%
ROIC/WACC1.65
Cap/Depr(3y)99.37%
Cap/Depr(5y)344.26%
Cap/Sales(3y)1.93%
Cap/Sales(5y)6.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)61.19%
EPS 3Y35.1%
EPS 5Y10.96%
EPS Q2Q%8.2%
EPS Next Y-4.43%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)23.68%
Revenue growth 3Y16.57%
Revenue growth 5Y13.84%
Sales Q2Q%11.12%
Revenue Next Year4.48%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y29.16%
EBIT growth 3Y27.48%
EBIT growth 5Y8.65%
EBIT Next Year10.43%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-206.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-142.63%
OCF growth 3YN/A
OCF growth 5YN/A

PRO-DEX INC / PDEX FAQ

Can you provide the ChartMill fundamental rating for PRO-DEX INC?

ChartMill assigns a fundamental rating of 5 / 10 to PDEX.


What is the valuation status for PDEX stock?

ChartMill assigns a valuation rating of 4 / 10 to PRO-DEX INC (PDEX). This can be considered as Fairly Valued.


Can you provide the profitability details for PRO-DEX INC?

PRO-DEX INC (PDEX) has a profitability rating of 6 / 10.


What is the financial health of PRO-DEX INC (PDEX) stock?

The financial health rating of PRO-DEX INC (PDEX) is 6 / 10.


What is the expected EPS growth for PRO-DEX INC (PDEX) stock?

The Earnings per Share (EPS) of PRO-DEX INC (PDEX) is expected to decline by -4.43% in the next year.